- $4.79bn
- $6.09bn
- CNY31.87bn
- 72
- 72
- 64
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28,994 | 29,707 | 30,554 | 28,998 | 31,873 |
Cost of Revenue | |||||
Gross Profit | -1,355 | 6,747 | 9,162 | 12,038 | 15,319 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 38,251 | 35,748 | 35,034 | 27,317 | 28,883 |
Operating Profit | -9,258 | -6,041 | -4,479 | 1,680 | 2,989 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10,225 | -6,984 | -6,012 | -33.8 | 2,033 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10,277 | -7,007 | -6,109 | -118 | 1,953 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -10,323 | -7,038 | -6,170 | -136 | 1,925 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10,325 | -7,045 | -6,190 | -136 | 1,925 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.99 | -1.23 | -1.07 | -0.006 | 0.357 |